Galderma Achieves FDA Approval of AKLIEF® (trifarotene) Case Study ガルデルマ社、AKLIEF®(トリファロテン)のFDA承認を取得 In October 2019, Galderma announced that the U.S. FDA approved AKLIEF® (trifarotene) Cream, 0.005% for the…Certara2020年11月9日
Danazol oral absorption modelling in the fasted dog: An example of mechanistic understanding of formulation effects on drug pharmacokinetics Publication Danazol oral absorption modelling in the fasted dog: An example of mechanistic understanding of formulation effects on drug pharmacokinetics Certara2020年10月30日
PBPK modeling supports approval of breakthrough cancer drug Video PBPK modeling supports approval of breakthrough cancer drug Pharmacyclics’ (now AbbVie) Imbruvica (ibrutinib) is an anticancer drug targeting B-cell malignancies. Leveraging the US…Certara2020年10月23日
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy Publication Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy Model-informed precision dosing (MIPD) has become synonymous with modern approaches for individualizing drug therapy, in…Certara2020年10月12日
Intro to Smart In Silico Tools to Aid in Translating In Vitro & In Vivo Studies On-Demand Webinar Intro to Smart In Silico Tools to Aid in Translating In Vitro & In Vivo Studies Safety issues account for about a quarter of the attrition in drug projects, and can…Certara2020年10月5日
Secondary Intelligence Fact Sheet Secondary Intelligence オフターゲットリスクを予測し、セカンダリーファーマコロジー解析を効率化することで、より安全な医薬品開発を実現。Certara2020年9月4日
VIVD: Virtual in vitro distribution model for the mechanistic prediction of intracellular concentrations of chemicals in in vitro toxicity assays Publication VIVD: Virtual in vitro distribution model for the mechanistic prediction of intracellular concentrations of chemicals in in vitro toxicity assays Certara2020年6月28日